David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?
Update: 2025-11-08
Description
Visit https://www.peervoice.com/RNT860 to view the entire programme with slides. After completing “David Jones, OBE, MD, PhD - New Options and Opportunities for Personalised Treatment of Primary Biliary Cholangitis: Have You Updated Your Approach?”, participants will be able to: Describe the contemporary approach to pharmacologic treatment of primary biliary cholangitis (PBC); Identify individuals with PBC who may benefit from initiation of second-line treatment options or a transition in second-line treatment approach; and Apply available data to guide the personalisation of second-line treatment choice for individuals with PBC based on person- and disease-specific characteristics (eg, presence of moderate-to-severe pruritus or compensated cirrhosis, prior treatment with fibrates or obeticholic acid [OCA]).
Comments
In Channel



